H D Bear - JoVE Visualize

Showing results (11-20 of 58) with videos related to

Pageof 6

Sort By:

Journal of Surgical Oncology|April 1, 1992

Stage III breast cancer: is neoadjuvant chemotherapy always necessary?J L Frank, D K McClish, K S Dawson, et al.

Surgical Oncology|August 1, 1992

Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastasesT M Tuttle, T H Inge, D S Lind, et al.

Cancer Research|March 15, 1988

Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleensH D Bear, B M Susskind, K A Close, et al.

Cancer Immunology, Immunotherapy : CII|August 14, 2001

Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trialH D Bear, J Roberts, D Cornell, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodesJ G McKinnon, S K Hoover, T H Inge, et al.

Neurological Research|April 1, 1997

Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytesR E Merchant, N G Baldwin, C D Rice, et al.

American Journal of Surgery|April 1, 1984

Colon and rectal carcinoma in the west of Scotland. Symptoms, histologic characteristics, and outcomeH D Bear, J MacIntyre, H J Burns, et al.

Cellular Immunology|August 1, 1992

Different signaling pathways induced by alpha-CD3 monoclonal antibody versus alloantigen on the basis of differential ornithine sensitivityP Mehrotra nee Tandon, D S Lind, H D Bear, et al.

Cancer Research|February 15, 1993

gamma-Interferon plays a key role in T-cell-induced tumor regressionT M Tuttle, C W McCrady, T H Inge, et al.

Journal of Surgical Oncology|February 1, 1991

Activation and in vitro expansion of tumor-reactive T lymphocytes from lymph nodes draining human primary breast cancersS K Hoover, J L Frank, C McCrady, et al.

Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:

Pageof 6

Journal of Surgical Oncology|April 1, 1992

Stage III breast cancer: is neoadjuvant chemotherapy always necessary?J L Frank, D K McClish, K S Dawson, et al.

Surgical Oncology|August 1, 1992

Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastasesT M Tuttle, T H Inge, D S Lind, et al.

Cancer Research|March 15, 1988

Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleensH D Bear, B M Susskind, K A Close, et al.

Cancer Immunology, Immunotherapy : CII|August 14, 2001

Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trialH D Bear, J Roberts, D Cornell, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodesJ G McKinnon, S K Hoover, T H Inge, et al.

Neurological Research|April 1, 1997

Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytesR E Merchant, N G Baldwin, C D Rice, et al.

American Journal of Surgery|April 1, 1984

Colon and rectal carcinoma in the west of Scotland. Symptoms, histologic characteristics, and outcomeH D Bear, J MacIntyre, H J Burns, et al.

Cellular Immunology|August 1, 1992

Different signaling pathways induced by alpha-CD3 monoclonal antibody versus alloantigen on the basis of differential ornithine sensitivityP Mehrotra nee Tandon, D S Lind, H D Bear, et al.

Cancer Research|February 15, 1993

gamma-Interferon plays a key role in T-cell-induced tumor regressionT M Tuttle, C W McCrady, T H Inge, et al.

Journal of Surgical Oncology|February 1, 1991

Activation and in vitro expansion of tumor-reactive T lymphocytes from lymph nodes draining human primary breast cancersS K Hoover, J L Frank, C McCrady, et al.

Pageof 6